Skip to content

Three-Dimensional Vascular Reconstruction of the Pancreas on Multidetector Computed Tomography Images and Its Impact on Patients Undergoing Pancreaticoduodenectomy

Three-Dimensional Vascular Reconstruction of the Pancreas on Multidetector Computed Tomography Images and Its Impact on Patients Undergoing Pancreaticoduodenectomy - A Prospective Observational Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05389917
Enrollment
25
Registered
2022-05-25
Start date
2022-05-30
Completion date
2023-06-01
Last updated
2022-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreaticoduodenectomy

Keywords

Inferior Pancreaticoduodenal artery, Multi detector Computed Tomography

Brief summary

Three-Dimensional Vascular Reconstruction of the Pancreas on Multi detector Computed Tomography images and its impact on patients undergoing Pancreatoduodenectomy - A Prospective Observational Study IPDA is difficult to identify in pre op in routine CECT images IPDA is difficult to identify in intra op Identification of those major blood vessels (SMA, MCA, Left Renal vein) that lie around the IPDA and then to measure the distances between these major vessels and the IPDA, helps to determine the location of the IPDA

Detailed description

Pancreaticoduodenectomy (PD) is a complex surgical procedure performed for benign and malignant indications . Vascular anatomy of the pancreatic head, is important in multiple aspects * Classical arterial anatomy is observed in 55-79% of cases * Arterial Variation is observed in around 25-30% of cases * Relationship of the tumor to the blood vessels determines the resectability of tumor The presence of anatomical variations may increase the risk of complications through * direct (bleeding due to intraoperative vessel injury) * indirect (postoperative ischemia of tissues and anastomotic leakage) Preoperative understanding of the vascular anatomy of the pancreatic head is important in order to reduce intraoperative bleeding. * IPDA is difficult to identify in pre op in routine CECT images. It is identified in only 20% of patients. * IPDA is difficult to identify in intra op because- It generally originates from the posterior wall of superior mesenteric artery (SMA).The origin of IPDA frequently varies, which makes it difficult to identify in some patients. It is surrounded by dense lymphovascular tissue, which makes it difficult to identify IPDA during surgery. IPDA can be identified in up to 86% of the time using 3D MDCT . Identification of those major blood vessels (SMA, MCA, Left Renal vein) that lie around the IPDA and then to measure the distances between these major vessels and the IPDA, helps to determine the location of the IPDA. In the existing studies, they have not defined the impact of identifying IPDA on intra operative parameters ( Operative time, Blood loss) These studies have not used uniform landmarks in the identification of IPDA

Interventions

PROCEDUREPancreaticoduodenectomy

In Pre Operative phase 64 Slice MD CT scan will be taken in all patients undergoing PD in pre op period 3D reconstruction of Peripancreatic vascular system using MDCT images Measure longitudinal distance between Root of Left renal vein, origin of IPDA Measure distance between origin of SMA , MCA and the IPDA In Intraoperative period Distance will be measured using standard disposable ruler from Root of Left renal vein to IPDA after Transection of Pancreas followed by specimen removal and to measure the distance between MCA, SMA and IPDA using standard disposable ruler .

Sponsors

Institute of Liver and Biliary Sciences, India
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

• Consecutive Patients undergoing pancreaticoduodenectomy during the study period at ILBS

Exclusion criteria

* If surgery is not proceeded for any cause like Presence of metastasis, Unreconstructable portal or SMV involvement , SMA involvement of \>180 degree * Refusal for consent

Design outcomes

Primary

MeasureTime frameDescription
Probability of identifying IPDA with in 1 cm of anticipated location from Left renal vein determined by preoperative 3D reconstructed MDCT images.During the ProcedureDuring the procedure distance will be measured between root of Left Renal vein to Origin of IPDA

Secondary

MeasureTime frameDescription
To correlate the location of IPDA predicted by 3D reconstruction of preoperative MDCT images with actual intraoperative location of MCA and SMA, after specimen removalDuring the ProcedureDuring the procedure distance will be measured between Origin of SMA and MCA to Origin of IPDA
To correlate the early ligation of IPDA with Blood Loss and Operative timeDuring the ProcedureBlood Loss during the procedure and time required to complete the pancreaticoduodenectomy procedure
Spectrum of arterial anomalies encountered during PancreaticoduodenectomyDuring The ProcedureAnatomy of vascular arcades arising from the celiac and superior mesenteric arteries will be noted during the procedure
To compare operative time between patients who undergo pre operative 3D vascular reconstruction on MD CT followed by Pancreaticoduodenectomy versus historical controls who have undergone pancreaticoduodenectomy at ILBSDuring the ProcedureOperative time of patients who have undergone pancreaticoduodenectomy during the study period is compared with historical cohorts
To compare blood loss between patients who undergo pre operative 3D vascular reconstruction on MD CT followed by Pancreaticoduodenectomy versus historical controls who have undergone pancreaticoduodenectomy at ILBSDuring the ProcedureBlood loss of patients who have undergone pancreaticoduodenectomy during the study period is compared with historical cohorts

Contacts

Primary ContactManoj Kumar YL, MBBS, MS
manojkumaryl91@gmail.com9164313430
Backup ContactPiyush Kumar Sinha, MBBS,MS,MCh
piyushkumarsinha@gmail.com9540946821

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026